BioCardia Director Andrew Scott Blank Granted 8,000 Stock Options

This Form 4 filing reports that Andrew Scott Blank, a director of BioCardia, Inc., was granted 8,000 stock options on July 6, 2026. The options have an exercise price of $1.20 per share and expire on July 6, 2036. The options vest entirely on the one-year anniversary of the grant date, contingent on Blank continuing as a service provider through that date. Following this transaction, Blank holds a total of 23,313 options. The filing represents a standard equity compensation award to a company director, with the options granted at fair market value as indicated by the $1.20 exercise price. This type of director compensation is common practice for public companies to align director interests with shareholder value creation.